Pharmaceutical

AstraZeneca to invest $2.5bn in R&D centre in China

AstraZeneca has announced a $2.5bn investment to establish the company’s sixth worldwide strategic R&D centre in China.

Mar 25, 2025 - 06:00
AstraZeneca to invest $2.5bn in R&D centre in China
AstraZeneca has announced a $2.5bn investment to establish the company’s sixth worldwide strategic R&D centre in China.
Read the original article

Tags:

Previous Article

FDA approves IND application for Everest’s cancer vaccine

Next Article

J&J boosts US operations with $55bn investment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Health Canada approves Arcutis’ ZORYVE foam for seborrheic dermatitis 

Health Canada approves Arcutis’ ZORYVE foam for seborrh...

Oct 22, 2024

Defender’s plans for motion sickness nasal gel stop with FDA rejection

Defender’s plans for motion sickness nasal gel stop wit...

Jan 31, 2024

Pan Cancer T raises funds through seed extension round

Pan Cancer T raises funds through seed extension round

Jul 14, 2024